尼泊尔着色性干皮病的临床与遗传特征
该研究纳入2014–2015年尼泊尔三级转诊中心连续转诊的17例着色性干皮病(XP)患者,收集中文临床数据并对唾液DNA进行覆盖8个XP基因及MC1R的二代测序。结果显示15例携带相同纯合无义XPC突变c.1243C>T,p.R415X,提示奠基者效应,且常见XPD/ERCC2杂合变异与MC1R R163Q变异。
要点
- 尼泊尔XP患者多携带纯合XPC p.R415X突变,提示奠基者效应。
- 12例患者发生皮肤癌,包括8例鳞状细胞癌和60例基底细胞癌,无黑色素瘤。
- NGS常发现XPD/ERCC2与MC1R变异,可能修饰临床表型。
核心结论
- 尼泊尔XP可能常见,15/17例携带相同纯合XPC p.R415X突变,提示奠基者效应。
- NGS常发现XPD/ERCC2和MC1R变异,可能修饰XP临床表达。
研究设计与样本
- 2014–2015年尼泊尔三级转诊中心连续转诊的全部XP患者,共17例,中位年龄15岁(范围1–32岁)。
- 使用标准化问卷收集临床数据,唾液样本提取DNA,NGS panel覆盖8个已知XP基因及MC1R。
主要发现
- 17例中12例有皮肤癌,包括8例鳞状细胞癌、60例基底细胞癌,3例需眶内容剜除的眼部癌,无黑色素瘤。
- 15例携带相同纯合无义XPC突变c.1243C>T,p.R415X。
- 唯一有早期严重晒伤反应及神经系统症状的患者携带纯合无义XPA突变p.W235X。
- XPD/ERCC2杂合错义变异见于5例,MC1R R163Q变异见于9例。
临床怎么用
- 尼泊尔XP患者常见严重表型,多因长期过度日晒且对疾病缺乏认知而就诊。
- 对尼泊尔疑似XP患者可优先关注XPC p.R415X突变检测。
局限性
- 样本量小(17例),仅来自单一尼泊尔三级转诊中心。
- 未报告对照人群或功能验证数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Little is known about xeroderma pigmentosum (XP) in Himalayan countries. OBJECTIVE: To describe clinical characteristics of XP in Nepal and investigate its genetic bases. METHODS: This study was carried out on all consecutive patients referred for XP to a Nepalese tertiary referral centre in 2014-2015. Clinical data were collected using a standardized questionnaire. DNA was extracted from salivary samples, and next-generation sequencing (NGS) was conducted using a panel covering all 8 known XP genes (classical XP (XP-A to XP-G) and XP variant) and a skin cancer modifier gene, the melanocortin 1 receptor gene (MC1R). RESULTS: Seventeen patients (median age: 15 years; range: 1-32) were included. Twelve had skin cancers (including a total of 8 squamous cell carcinomas, 60 basal cell carcinomas, ocular carcinomas requiring an orbital exenteration in 3 patients, but no melanoma). Fifteen patients carried the same homozygous non-sense XPC mutation c.1243C>T, p.R415X. A homozygous non-sense XPA mutation (p.W235X) was found in the only patient with a history of early severe sunburn reaction and associated neurological symptoms. Associated genetic alterations included heterozygous missense variants in XPD/ERCC2 gene and the presence of MC1R variant R163Q in 5 and 9 patients, respectively. CONCLUSION: Although not previously reported, XP seems frequent in Nepal. Patients often presented with a very severe phenotype after a long history of excessive sun exposure without knowledge of the disease. Fifteen of 17 had the same p.R415X XPC mutation, which seems very specific of XP in Nepal, suggesting a founder effect. NGS analyses frequently revealed associated genetic alterations which could play a modifier role in the clinical expression of the disease.
引用
- Espi P, Parajuli S, Benfodda M, et al. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal. J Eur Acad Dermatol Venereol. 2017. PMID: 29178624. doi:10.1111/jdv.14717
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。